Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, July 2010

M Unemo; D Golparian; A Hestner

doi:10.2807/ese.16.06.19792-en

Rapid communications Open Access

Like 0

Download

Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, July 2010

M Unemo¹, D Golparian¹, A Hestner²
View Affiliations Hide Affiliations

Affiliations: ¹ Swedish Reference Laboratory for Pathogenic Neisseria, Department of Laboratory Medicine, Microbiology, Örebro University Hospital, Örebro, Sweden ² Department of Dermatology and Venereology, Kärnsjukhuset, Skövde, Sweden

Correspondence:
M Unemo
magnus.unemo orebroll.se
View Citation Hide Citation

Citation style for this article: Unemo M, Golparian D, Hestner A. Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, July 2010. Euro Surveill. 2011;16(6):pii=19792. https://doi.org/10.2807/ese.16.06.19792-en Received: 24 Jan 2011

Abstract

This report describes one case of verified treatment failure of pharyngeal gonorrhoea using ceftriaxone in Sweden. Previous reports described verified treatment failure of urogenital gonorrhoea using the internationally recommended first-line drug cefixime, but not with ceftriaxone, the last remaining option for empirical treatment of gonorrhoea. Enhanced awareness of clinical failures, pharmacodynamic considerations, follow-up and test of cure, adherence to appropriate case management and treatment guidelines as well as verification/falsification of presumed clinical treatment failures should be emphasised worldwide.